228 related articles for article (PubMed ID: 27365167)
1. Advances in technology and business potential of new drug delivery systems.
Momin M; Disouza J; Patravale V
Drug Deliv Transl Res; 2016 Aug; 6(4):341. PubMed ID: 27365167
[No Abstract] [Full Text] [Related]
2. Cancer nanotechnology: small, but heading for the big time.
Nat Rev Drug Discov; 2007 Mar; 6(3):174-5. PubMed ID: 17396287
[No Abstract] [Full Text] [Related]
3. 9th International drug delivery technologies & deal-making summit.
Panzner S; Smith PL
Expert Opin Drug Deliv; 2005 Jan; 2(1):189-90. PubMed ID: 16296745
[TBL] [Abstract][Full Text] [Related]
4. Drug Delivery 2007--New technologies, partnering and strategies for the future.
Stevenson L
IDrugs; 2007 Jun; 10(6):388-90. PubMed ID: 17642001
[No Abstract] [Full Text] [Related]
5. Nanotechnology: intelligent design to treat complex disease.
Couvreur P; Vauthier C
Pharm Res; 2006 Jul; 23(7):1417-50. PubMed ID: 16779701
[TBL] [Abstract][Full Text] [Related]
6. Biotechnology's metamorphosis into a drug discovery industry.
Drews J
Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258
[No Abstract] [Full Text] [Related]
7. Venturing into drug discovery.
Steinmetz M
Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
[No Abstract] [Full Text] [Related]
8. Vaccine manufacturing: challenges and solutions.
Ulmer JB; Valley U; Rappuoli R
Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
[TBL] [Abstract][Full Text] [Related]
9. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
10. The evolving role of collaboration in biotechnology.
Gower JM
Nat Biotechnol; 1998 May; 16 Suppl():31-2. PubMed ID: 9591261
[No Abstract] [Full Text] [Related]
11. The power of genomics to transform the biotechnology industry.
Haseltine WA
Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
[No Abstract] [Full Text] [Related]
12. Private company profiles.
Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
[No Abstract] [Full Text] [Related]
13. Lessons from 54 years of pharmaceutical research.
Firestone RA
Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986
[No Abstract] [Full Text] [Related]
14. In silico drug discovery: tools for bridging the NCE gap.
Larvol BL; Wilkerson LJ
Nat Biotechnol; 1998 May; 16 Suppl():33-4. PubMed ID: 9591262
[No Abstract] [Full Text] [Related]
15. Bigger companies for better drugs?
Lancet; 1995 Sep; 346(8975):585. PubMed ID: 7650996
[No Abstract] [Full Text] [Related]
16. The lost science of formulation.
Brown MB
Drug Discov Today; 2005 Nov; 10(21):1405-7. PubMed ID: 16243254
[No Abstract] [Full Text] [Related]
17. Prescription for an ailing pharmaceutical industry.
Demain AL
Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
[No Abstract] [Full Text] [Related]
18. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
Brown D
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
[TBL] [Abstract][Full Text] [Related]
19. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
20. Advances in solid dosage form manufacturing technology.
Andrews GP
Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2935-49. PubMed ID: 17855217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
